Suvretta Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $88.2M | Sell |
|
|||||
|
2025
Q2 | $64M | Hold |
|
|||||
|
2025
Q1 | $36.9M | Buy |
|
|||||
|
2024
Q4 | $50.5M | Buy |
|
|||||
|
2024
Q3 | $41.4M | Hold |
|
|||||
|
2024
Q2 | $45M | Buy |
|
|||||
|
2024
Q1 | $77.8M | Sell |
|
|||||
|
2023
Q4 | $93.8M | Buy |
|
|||||
|
2023
Q3 | $27.9M | Buy |
|
|||||
|
2023
Q2 | $29.8M | Buy |
|
|||||
|
2023
Q1 | $9.98M | Buy |
|
|||||
|
2022
Q4 | $11.7M | Buy |
|
|||||
|
2022
Q3 | $25.6M | Buy |
|
|||||
|
2022
Q2 | $23.4M | Buy |
|
|||||
|
2022
Q1 | $35.3M | Buy |
|
|||||
|
2021
Q4 | $30.8M | Buy |
|
|||||
|
2021
Q3 | $17.8M | Buy |
|
|||||
|
2021
Q2 | $12.4M | Buy |
|
|||||
|
2021
Q1 | $12M | Buy |
|